Accueil › Maladie de Crohn › Texas › Tyler
Essais cliniques pour Maladie de Crohn à Tyler, TX
16 études pour Maladie de Crohn recherchent des participants dans et autour de Tyler (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Recrutement en coursPhase 3
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Recrutement en coursPhase 3
- Tyler Research Institute ( Site 5001), Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Recrutement en coursPhase 2
- Tyler Research Institute /ID# 265545, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2/3
- Tyler Research Institute, LLC, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- Tyler Research Institute, LLC, Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Recrutement en coursPhase 3
- Tyler Research Institute, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Recrutement en coursPhase 4
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 3
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Recrutement en coursPhase 3
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Recrutement en coursPhase 2
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recrutement en coursPhase 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Recrutement en coursPhase 2
- Mirador Therapeutics Selected Site, Tyler
Essais pour Maladie de Crohn dans d'autres villes
- New York City, NY35 études
- Cleveland, OH19 études
- St. Louis, MO19 études
- Boston, MA19 études
- Miami, FL19 études
- Orlando, FL17 études
- Houston, TX17 études
- Atlanta, GA17 études
- San Diego, CA15 études
- San Antonio, TX15 études
- Los Angeles, CA15 études
- Philadelphia, PA13 études
Autres études à Tyler
- Cancer du poumon non à petites cellules20 études
- Colite ulcéreuse14 études
- Cancer colorectal8 études
- Insuffisance cardiaque8 études
- Cancer (tous types)7 études
- Cancer de l'ovaire7 études
- Cancer de l'endomètre6 études
- Carcinome épidermoïde de la tête et du cou6 études
- Cancer du sein6 études
- Cancer métastatique5 études
- Maladie inflammatoire chronique de l'intestin5 études
- Leucémie lymphocytaire chronique5 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.